Edegem

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer2 trials
• Colorectal cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Multiple sclerosis1 trial

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Completed2 trials
• Terminated2 trials

Lead sponsor

• Sanofi4 trials

Closed trials

• Terminated

  Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA

  NCT05245071· Phase 2· Sanofi· Source

• Completed

  A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

  NCT05104567· Phase 2· Sanofi· Source

• Terminated

  Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer

  NCT05071053· Phase 2· Sanofi· Source

• Completed

  Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)

  NCT04411641· Phase 3· Sanofi· Source